Clicky

CELG $77.73 -0.35 (-0.45%)

Celgene Corp


Stock Charts Stock Price Earnings Industry Stocks Company Profile

Celgene Stock Charts

The 5 year and 1 year stock charts are below.


Celgene 5 year stock chart
Celgene 5 year stock chart

50 Day Moving Average

The 50 Day Moving Average is at $83.33 which is 6.72% above the stock price of $77.73.

200 Day Moving Average

The 200 Day Moving Average is at 102.79 which is 24.38% above the stock price of $77.73.

CELG Stock Price

Below are a few key dates for the stock price.


Year To Date

Jun
18
Monday

The most recent stock price is $77.73.

The Year To Date (YTD) return is -26.78%.

52 Week Low

May
21
Monday

The 52 Week Low stock price is $74.13 set on Mon, May 21, 2018 which is 29 days ago.

The current price per share is 4.86% above the 52 week low.

52 Week High

Oct 2017
02
Monday

The 52 Week High stock price is $147.17 set on Mon, Oct 2, 2017 which is 260 days ago.

The current price per share is -47.18% below the 52 week high.

All Time High

Oct 2017
02
Monday

The All Time High stock price is $147.17 set on Mon, Oct 2, 2017 which is 260 days ago.

The current price per share is -47.18% below the all time high.

Earnings

Below is the EPS, P/E Ratio and Earnings Date.


The Earnings Per Share (EPS) is $3.58.

The Price To Earnings (P/E) Ratio is 21.72.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.

Jan
25
Thursday

The Earnings Release Date for Celgene Corp was Thu, Jan 25, 2018.

Since this earnings release 145 days ago, the stock price is down by -24.61%.

May
04
Friday

The most recent Earnings Release Date was on Fri, May 4, 2018, which was 46 days ago.

Since this earnings date, the stock price is down by -8.98%.

Celgene Dividend

Below is important Dividend information.


CELG currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Biotech & Pharma Industry

Below are other stocks in the same industry as Celgene.


CELG Company Profile

Learn more about Celgene.


Celgene Corp LogoCelgene Corp is a Health Care stock that trades on the NASDAQ and has a market capitalization of $55.19 Billion.

http://www.celgene.comCelgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Spend a few minutes browsing the Celgene Corp, web site at http://www.celgene.com.

For more information and analysis of CELG, visit Bloomberg, Google Finance, Nasdaq, Yahoo Finance.